Capricor Therapeutics CAPR Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $287.85M+2,450% | $11.29M-23.2% | $14.69M+53.0% | $9.6M-72.5% | ||
| $30.28M-78.4% | $140.23M+466% | $24.79M-22.1% | $31.82M— | ||
| $4.75M+217% | $1.5M+50.7% | $995.78K+8.2% | $919.89K-20.7% | ||
| $322.94M+97.7% | $163.39M+221% | $50.86M+18.6% | $42.89M+17.7% | ||
| $18.31M+229% | $5.56M0.0% | $5.56M+21.2% | $4.59M+156% | ||
| $13.54M+931% | $1.31M-36.0% | $2.05M-12.8% | $2.35M-16.7% | ||
| $1.16M+423% | $221.7K-17.3% | $268.17K0.0% | $268.17K-2.7% | ||
| $355.95M+109% | $170.48M+190% | $58.73M+17.2% | $50.09M+21.2% | ||
| $1.65M-49.6% | $3.28M-47.5% | $6.25M+29.3% | $4.83M+55.1% | ||
| $15.56M+217% | $4.91M+17,760% | $27.48K-69.2% | $89.23K— | ||
| $12M0.0% | $12M-50.6% | $24.27M+35.0% | $17.98M— | ||
| $202.38K-75.8% | $834.8K+11.4% | $749.11K+9.8% | $682.04K+63.3% | ||
| $35.84M+70.4% | $21.03M-32.8% | $31.27M+32.6% | $23.59M+471% | ||
| $14.32M+2,224% | $616.32K-58.5% | $1.49M-20.8% | $1.88M-23.4% | ||
| $14.52M+901% | $1.45M-35.1% | $2.24M+1.6% | $2.2M-23.4% | ||
| $14.32M+259% | $3.99M-17.9% | $4.86M-67.0% | $14.72M+153% | ||
| $50.16M+100% | $25.02M-30.8% | $36.13M-5.7% | $38.31M+285% | ||
| —— | —— | —— | —— | ||
| $57.37K+25.9% | $45.58K+46.3% | $31.15K+23.4% | $25.24K+4.4% | ||
| $610.33M+77.3% | $344.22M+89.4% | $181.7M+22.2% | $148.74M+6.7% | ||
| -$304.88M-52.6% | -$199.83M-25.4% | -$159.37M-16.3% | -$137.08M-26.9% | ||
| $283.15K-72.4% | $1.03M+335% | $235.81K+124% | $105.24K— | ||
| $305.79M+110% | $145.46M+544% | $22.6M+91.8% | $11.79M-62.4% | ||
| $355.95M+109% | $170.48M+190% | $58.73M+17.2% | $50.09M+21.2% | ||
| $30.28M-78.4% | $140.23M— | —— | —— | ||
| $13.54M+931% | $1.31M-36.0% | $2.05M-12.8% | $2.35M-16.7% | ||
| $13.54M+931% | $1.31M-36.0% | $2.05M-12.8% | $2.35M-16.7% | ||
| $1.16M+423% | $221.7K-17.3% | $268.17K0.0% | $268.17K-2.7% | ||
| $13.54M+931% | $1.31M-36.0% | $2.05M-12.8% | $2.35M-16.7% | ||
| $15.56M+217% | $4.91M— | —— | —— | ||
| $15.56M+217% | $4.91M— | —— | —— | ||
| $14.52M+901% | $1.45M-74.1% | $5.61M+0.6% | $5.58M-10.7% | ||
| $610.33M+77.3% | $344.22M+89.4% | $181.7M+22.2% | $148.74M+6.7% | ||
| $57.37K+25.9% | $45.58K+46.3% | $31.15K+23.4% | $25.24K+4.4% | ||
| $6.42M— | $0— | —— | —— | ||
| $59.17K-99.4% | $10.37M0.0% | $10.37M+1,794% | $547.58K+39.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Capricor Therapeutics's total assets?
- Capricor Therapeutics (CAPR) holds $326.3M in total assets, up 112.2% year over year.
- How much debt does Capricor Therapeutics have?
- Capricor Therapeutics carries $14.8M in total debt against $278.7M of shareholders' equity, a debt-to-equity ratio of 0.05.
- How much cash does Capricor Therapeutics have?
- Capricor Therapeutics holds $105.4M in cash and equivalents.
- Can Capricor Therapeutics cover its short-term obligations?
- Its current ratio is 8.42 — current assets exceed current liabilities.
- Where does Capricor Therapeutics's balance sheet data come from?
- Every line is extracted from Capricor Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.